TraceLink to Host Webinars Following Recently Announced FDA Data Exchange Guidance for DSCSA Compliance

WAKEFIELD, MA--(Marketwired - Dec 2, 2014) -  TraceLink Inc., the leader in protecting patient safety and enabling health for global Life Sciences, today announced that it will host two webinars for pharmaceutical supply chain companies that do not yet have a solution for ensuring compliance under the Drug Supply Chain Security Act (DSCSA), which takes effect on January 1, 2015. The informational sessions follow the recently announced FDA interoperable data exchange guidance provided on November 26, and will provide pharmaceutical manufacturers and distributors with a clear overview of any final steps they must take to ensure they are ready to exchange compliant Transaction History (TH), Transaction Information (TI), and Transaction Statement (TS) documents with their trading partners under DSCSA. The company will also share details about how easy it is to connect to the TraceLink Life Sciences Cloud, the largest track and trace network serving more than 50,000 connected members of the pharmaceutical supply chain, and its innovative DSCSA in a Week implementation program. The webinars are scheduled for Tuesday, December 2 at 1:00pm EST and Tuesday, December 9 at 1:00pm EST.

"Our effort to help pharmaceutical companies meet the January 1, 2015 DSCSA deadline dates back to before DSCSA was signed into law -- and now that we're less than four weeks away, we're committed to helping anyone implement a cost-effective DSCSA plan," said Shabbir Dahod, president and CEO of TraceLink. "With the largest track and trace network in the Life Sciences industry, over a decade of experience connecting supply chain companies of all sizes and technical capabilities -- and 14 of the top 20 global pharmaceutical companies as customers, we deeply understand the complex operational challenges associated with DSCSA regulations. This is how we've been able to ensure that TraceLink customers could ship commercial goods to the Big Three with DSCSA compliant documents well in advance of January 1 -- and it's why more Life Sciences companies choose TraceLink to meet DSCSA requirements than any other single alternative."

Specifically designed for pharmaceutical manufacturers, wholesalers, repackagers and dispensers, the TraceLink Life Sciences Cloud connects more than 50,000 trading partners to deliver end-to-end DSCSA compliance. With a single connection to the TraceLink network, new customers achieve compliance with all provisions of DSCSA regulations and interoperability.

To understand how TraceLink can help you prepare for DSCSA and implement its proven and cost-effective, flexible platform for global serialization, track and trace, and reporting for China, Brazil and other countries, visit www.tracelink.com.

About TraceLink
TraceLink protects patients, enables health and ensures compliance for companies across the global Life Sciences supply network, including fourteen of the top-20 global pharmaceutical companies. Leading businesses trust the TraceLink Life Sciences Cloud, our Amazon AWS-based cloud application platform, to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn.

TraceLink is funded by FirstMark Capital. FirstMark Capital is an early stage venture capital firm based in New York City. FirstMark's mission is to partner with exceptional entrepreneurs who are changing the world by solving meaningful problems. FirstMark has built a deeply engaged community among the extraordinary teams in the FirstMark network to spread ideas and opportunities. FirstMark is privileged to work alongside the founders of remarkable businesses like Pinterest, Lumosity, Aereo, TapAd, Shopify, Riot Games, and dozens more. Visit FirstMark in New York City or online at firstmarkcap.com and @FirstMarkCap.